drugset / Trial / NCT04180397

Controlled Fluid Removal in Critical Ill Patients With Fluid Overload in the Intensive Care Unit.

NCT04180397

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates the benefits and harms of goal directed fluid removal with furosemide versus placebo in critical ill adult patients with fluid overload in the intensive care unit. Half of the patients will receive furosemide and the other half placebo. The treatment will continue until the excess fluid is excreted.

Timeline

Start
2020-08-17
Primary completion
2027-04-30
Completion
2028-04-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Furosemide Other / unclassified 5 mg Intravenous
Comparator Furosemide Other / unclassified 20 mg Intravenous
Comparator Furosemide Other / unclassified 40 mg Intravenous

Indications

No indication recorded.